Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06277271 · ClinicalTrials.gov registry record · NA
E-cigarettes as a Harm Reduction Strategy
A NA study, sponsored by Prisma Health-Upstate.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT06277271 is a NA study that has completed, run by Prisma Health-Upstate. The registered enrollment target is 30 participants.
The verdict
NCT06277271, a NA study, has completed, sponsored by Prisma Health-Upstate.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
E-cigarettes have emerged as an effective strategy for replacing cigarettes among smokers from the general population, but there is a dearth of studies investigating their utility in replacing cigarettes among smokers with opioid use disorder (OUD). This study aims to evaluate the feasibility and acceptability of implementing a cigarette harm reduction intervention involving e-cigarettes in office-based buprenorphine clinics.
Interventions
- OTHER E-cigarette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-06-20 |
| Est. Completion | 2024-03-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06277271
The ClinicalTrials.gov registry entry for NCT06277271 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Prisma Health-Upstate, which has 67 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which E-cigarette is the first listed.
NCT06277271 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06277271 about?
NCT06277271 is a clinical study titled "E-cigarettes as a Harm Reduction Strategy". E-cigarettes have emerged as an effective strategy for replacing cigarettes among smokers from the general population, but there is a dearth of studies investigating their utility in replacing cigarettes among smokers with opioid use disorder (OUD). This study aims to evaluate the feasibility and ac...
What is the current status of trial NCT06277271?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2023-06-20. Estimated completion is 2024-03-18.
What interventions are being tested in trial NCT06277271?
The interventions under investigation include: E-cigarette (OTHER).
Who is sponsoring clinical trial NCT06277271?
This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.